Pages that link to "Q37325639"

The following pages link to Polymeric drug delivery of platinum-based anticancer agents (Q37325639):

Displaying 40 items.

• The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs (Q28066801) (← links)
• Engineering Biomaterial-Drug Conjugates for Local and Sustained Chemotherapeutic Delivery (Q28087367) (← links)
• Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads (Q33506479) (← links)
• Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy (Q34005179) (← links)
• Nanocarriers for delivery of platinum anticancer drugs. (Q34338695) (← links)
• Rationally engineered polymeric cisplatin nanoparticles for improved antitumor efficacy (Q35173143) (← links)
• α(V)β(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug (Q35981228) (← links)
• Cisplatin-loaded core cross-linked micelles: comparative pharmacokinetics, antitumor activity, and toxicity in mice. (Q36058925) (← links)
• Rationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacy (Q36070256) (← links)
• Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity (Q36094353) (← links)
• Nanoscale metal-organic frameworks for biomedical imaging and drug delivery (Q37182960) (← links)
• Fourth generation phosphorus-containing dendrimers: prospective drug and gene delivery carrier. (Q37378143) (← links)
• Targeting and delivery of platinum-based anticancer drugs (Q38050063) (← links)
• Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer (Q38633157) (← links)
• Preparation, Characterization, and Antitumor Activities of Miriplatin-Loaded Liposomes (Q38795899) (← links)
• Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin (Q38832616) (← links)
• Magnetically Targeted Nanocapsules for PAA-Cisplatin-Conjugated Cores in PVA/SPIO Shells via Surfactant-Free Emulsion for Reduced Nephrotoxicity and Enhanced Lung Cancer Therapy (Q38912446) (← links)
• Beyond platinum: synthesis, characterization, and in vitro toxicity of Cu(II)-releasing polymer nanoparticles for potential use as a drug delivery vector (Q39002265) (← links)
• Mitochondrial mode of action of a thymidine-based cisplatin analogue breaks resistance in cancer cells (Q39638924) (← links)
• Preparation, characterisation and preliminary antitumour activity evaluation of a novel nanoparticulate system based on a cisplatin-hyaluronate complex and N-trimethyl chitosan (Q39758165) (← links)
• Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer (Q41382500) (← links)
• A core cross-linked polymeric micellar platium(IV) prodrug with enhanced anticancer efficiency (Q43411545) (← links)
• The effect of sodium thiosulfate on the metabolism of cis-platin in human plasma in vitro (Q43529077) (← links)
• Shell crosslinked knedel-like nanoparticles for delivery of cisplatin: effects of crosslinking (Q43602743) (← links)
• The role of the basis set and the level of quantum mechanical theory in the prediction of the structure and reactivity of cisplatin. (Q43829665) (← links)
• Platinum (IV) pro-drug conjugated NaYF4 :Yb(3 ) /Er(3 ) nanoparticles for targeted drug delivery and up-conversion cell imaging. (Q45064469) (← links)
• N-acetyl-L-cysteine modulates the metabolism of cis-platin in human plasma in vitro. (Q45241480) (← links)
• Comparative hydrolysis and plasma protein binding of cis-platin and carboplatin in human plasma in vitro. (Q45795847) (← links)
• Fortification of blood plasma from cancer patients with human serum albumin decreases the concentration of cisplatin-derived toxic hydrolysis products in vitro (Q46834044) (← links)
• Chemoprotection by D-methionine against cisplatin-induced side-effects: insight from in vitro studies using human plasma. (Q46959686) (← links)
• Cyclodextrin polymers as nanocarriers for sorafenib. (Q47806297) (← links)
• Following the stability of amphiphilic nanoaggregates by using intermolecular energy transfer. (Q51747720) (← links)
• Fibrin gels loaded with cisplatin and cisplatin-hyaluronate complexes tested in a subcutaneous human melanoma model. (Q53497534) (← links)
• Protected and De-protected Platinum(IV) Glycoconjugates With GLUT1 and OCT2-Mediated Selective Cancer Targeting: Demonstrated Enhanced Transporter-Mediated Cytotoxic Properties and (Q57300005) (← links)
• Synthesis andin vitroactivity of platinum containing 2-oxazoline-based glycopolymers (Q57352955) (← links)
• Nanoparticles of chitosan conjugated to organo-ruthenium complexes (Q57393553) (← links)
• Synthesis of a glycopolymeric PtII carrier and its induction of apoptosis in resistant cancer cells (Q58385433) (← links)
• The Biological Side of Water-Soluble Arene Ruthenium Assemblies (Q59043441) (← links)
• Design of a Novel Theranostic Nanomedicine (III): Synthesis and Physicochemical Properties of Tumor-Targeting Cisplatin Conjugated to a Hydrophilic Polyphosphazene (Q89907287) (← links)
• Targeted Delivery of Cisplatin-Derived Nanoprecursors via a Biomimetic Yeast Microcapsule for Tumor Therapy by the Oral Route (Q90533360) (← links)